ARTICLE | Company News
Accium BioSciences Inc., PrognosDx deal
October 31, 2011 7:00 AM UTC
The companies partnered to develop and commercialize predictive histone biomarkers tests using PrognosDx's epigenetic technology with Accium's accelerator mass spectrometry technology. Details were no...